MedPath

Impact of Pelvic Exercise guidance on Urinary loss and pelvic Organ Falls

Not Applicable
Conditions
Stress Urinary incontinence
Women
C12.777.934.852.249
M01.975
Registration Number
RBR-4hz5vn
Lead Sponsor
niversidade Estadual de Campinas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Women with urinary incontinence with predominance of stress urinary incontinence; Women who voluntarily accept and sign the Informed Consent Form (TCLE); Women who have a cell phone; Know how to read and write.

Exclusion Criteria

Neurological problems that compromise the understanding for the practice of exercises, or suggestive of neurogenic bladder; Diabetes Mellitus; Total absence of muscle contraction of the pelvic floor (P = 0); pelvic floor hypertonicity; Anterior surgery of the pelvic floor; Prolapse of pelvic organs greater than stage II; Use of local hormone; Proven or suspected pregnancy; Prior treatment for urinary incontinence; Three or more lower urinary tract infections in the last 12 months; Ultrasound image with poor resolution for analysis.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected outcome 1:Improvement in the urinary incontinence complaint, determined through the ICIQ UI-SF (International Consultation on Incontinence Questionnaire - Short Form), at the beginning of the study and at the end of the study.
Secondary Outcome Measures
NameTimeMethod
Expected outcome 2:Strength gain in the contraction of the pelvic floor muscles, assessed by digital palpation, with the modified OXFORD scale, after 6 months of treatment.;Expected outcome 3:Improvement in the human body limitation scores, psychosocial impact and social embarrassment due to urinary incontinence, evaluated by the I-QOL (Incontinence Quality of life Questionnaire) questionnaire, after 06 months of treatment.;Expected outcome 3:Greater thickness of the anus levator muscle, smaller area of the genital hiatus and urethral mobility, assessed by 3D translabial ultrasonography, after 6 months of treatment.
© Copyright 2025. All Rights Reserved by MedPath